65 related articles for article (PubMed ID: 10541324)
1. Molecular correlations in phenylketonuria: mutation patterns and corresponding biochemical and clinical phenotypes in a heterogeneous California population.
Enns GM; Martinez DR; Kuzmin AI; Koch R; Wakeem CK; Woo SL; Eisensmith RC; Packman S
Pediatr Res; 1999 Nov; 46(5):594-602. PubMed ID: 10541324
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of phenylketonuria and a correlation between genotype and phenotype in a heterogeneous southeastern US population.
Eisensmith RC; Martinez DR; Kuzmin AI; Goltsov AA; Brown A; Singh R; Elsas LJ II; Woo SL
Pediatrics; 1996 Apr; 97(4):512-6. PubMed ID: 8632937
[TBL] [Abstract][Full Text] [Related]
3. Relationship between mutation genotype and biochemical phenotype in a heterogeneous Spanish phenylketonuria population.
Desviat LR; Pérez B; García MJ; Martínez-Pardo M; Baldellou A; Arena J; Sanjurjo P; Campistol J; Couce ML; Fernández A; Cardesa J; Ugarte M
Eur J Hum Genet; 1997; 5(4):196-202. PubMed ID: 9359039
[TBL] [Abstract][Full Text] [Related]
4. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan.
Okano Y; Kudo S; Nishi Y; Sakaguchi T; Aso K
J Hum Genet; 2011 Apr; 56(4):306-12. PubMed ID: 21307867
[TBL] [Abstract][Full Text] [Related]
6. Validation of PAH genotype-based predictions of metabolic phenylalanine hydroxylase deficiency phenotype: investigation of PKU/MHP patients from Lithuania.
Kasnauskiene J; Cimbalistiene L; Kucinskas V
Med Sci Monit; 2003 Mar; 9(3):CR142-6. PubMed ID: 12640344
[TBL] [Abstract][Full Text] [Related]
7. Molecular and phenotypic characteristics of patients with phenylketonuria in Serbia and Montenegro.
Stojiljkovic M; Jovanovic J; Djordjevic M; Grkovic S; Cvorkov Drazic M; Petrucev B; Tosic N; Karan Djurasevic T; Stojanov L; Pavlovic S
Clin Genet; 2006 Aug; 70(2):151-5. PubMed ID: 16879198
[TBL] [Abstract][Full Text] [Related]
8. Variations in genotype-phenotype correlations in phenylketonuria patients.
Santos LL; Fonseca CG; Starling AL; Januário JN; Aguiar MJ; Peixoto MG; Carvalho MR
Genet Mol Res; 2010 Jan; 9(1):1-8. PubMed ID: 20082265
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the phenylalanine hydroxylase (PAH) gene in Brazilian patients with phenylketonuria.
Acosta A; Silva W; Carvalho T; Gomes M; Zago M
Hum Mutat; 2001 Feb; 17(2):122-30. PubMed ID: 11180595
[TBL] [Abstract][Full Text] [Related]
10. The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients.
Rivera I; Cabral A; Almeida M; Leandro P; Carmona C; Eusébio F; Tasso T; Vilarinho L; Martins E; Lechner MC; de Almeida IT; Konecki DS; Lichter-Konecki U
Mol Genet Metab; 2000 Mar; 69(3):195-203. PubMed ID: 10767174
[TBL] [Abstract][Full Text] [Related]
11. [Phenotypic expression of 12 mutations of the phenylalanine hydroxylase gene].
Rey F; Abadie V; Lyonnet S; Berthelon M; Caillaud C; Melle D; Labrune P; Saudubray JM; Munnich A; Rey J
Arch Fr Pediatr; 1992 Oct; 49(8):705-10. PubMed ID: 1288453
[TBL] [Abstract][Full Text] [Related]
12. Analysis of phenylalanine hydroxylase genotypes and hyperphenylalaninemia phenotypes using L-[1-13C]phenylalanine oxidation rates in vivo: a pilot study.
Treacy EP; Delente JJ; Elkas G; Carter K; Lambert M; Waters PJ; Scriver CR
Pediatr Res; 1997 Oct; 42(4):430-5. PubMed ID: 9380432
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of genotype and intellectual phenotype in untreated phenylketonuric children].
Yuan L; Fang B; Wang M; Wang T; Huang S; Yang T; Zhao S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):297-9. PubMed ID: 9758878
[TBL] [Abstract][Full Text] [Related]
14. Relationship among genotype, biochemical phenotype, and cognitive performance in females with phenylalanine hydroxylase deficiency: report from the Maternal Phenylketonuria Collaborative Study.
Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
Pediatrics; 1999 Aug; 104(2 Pt 1):258-62. PubMed ID: 10429004
[TBL] [Abstract][Full Text] [Related]
15. Phenylketonuria mutations in Northern China.
Song F; Qu YJ; Zhang T; Jin YW; Wang H; Zheng XY
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S107-18. PubMed ID: 16256386
[TBL] [Abstract][Full Text] [Related]
16. Biochemical phenotype and its relationship with genotype in hyperphenylalaninemia heterozygotes.
Mallolas J; Milà M; Lambruschini N; Cambra FJ; Campistol J; Vilaseca MA
Mol Genet Metab; 1999 Jun; 67(2):156-61. PubMed ID: 10356315
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of phenylketonuria in Lithuania.
Kasnauskiene J; Giannattasio S; Lattanzio P; Cimbalistiene L; Kucinskas V
Hum Mutat; 2003 Apr; 21(4):398. PubMed ID: 12655550
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of phenylketonuria patients from Morocco: high prevalence of mutation G352fsdelG and detection of a novel mutation p.K85X.
Dahri S; Desviat LR; Pérez B; Leal F; Ugarte M; Chabraoui L
Clin Biochem; 2010 Jan; 43(1-2):76-81. PubMed ID: 19786003
[TBL] [Abstract][Full Text] [Related]
19. Predicting a clinical/biochemical phenotype for PKU/MHP patients with PAH gene mutations.
Kasnauskiene J; Cimbalistiene L; Kucinskas V
Genetika; 2008 Oct; 44(10):1397-403. PubMed ID: 19062537
[TBL] [Abstract][Full Text] [Related]
20. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
